Insurance - Specialty
Compare Stocks
5 / 10Stock Comparison
FNF vs ICE vs CME vs FAF vs CBOE
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Insurance - Specialty
Financial - Data & Stock Exchanges
FNF vs ICE vs CME vs FAF vs CBOE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Specialty | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Insurance - Specialty | Financial - Data & Stock Exchanges |
| Market Cap | $13.53B | $88.45B | $104.07B | $7.14B | $35.47B |
| Revenue (TTM) | $14.26B | $12.64B | $6.52B | $6.01B | $4.71B |
| Net Income (TTM) | $602M | $3.30B | $4.24B | $673M | $1.10B |
| Gross Margin | 65.1% | 61.9% | 86.1% | 74.3% | 48.9% |
| Operating Margin | 9.8% | 38.7% | 64.9% | 14.8% | 32.1% |
| Forward P/E | 8.7x | 19.5x | 23.5x | 10.9x | 27.0x |
| Total Debt | $4.77B | $20.28B | $3.76B | $1.91B | $1.68B |
| Cash & Equiv. | $2.38B | $837M | $4.42B | $1.39B | $2.22B |
FNF vs ICE vs CME vs FAF vs CBOE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Fidelity National F… (FNF) | 100 | 164.0 | +64.0% |
| Intercontinental Ex… (ICE) | 100 | 160.6 | +60.6% |
| CME Group Inc. (CME) | 100 | 157.1 | +57.1% |
| First American Fina… (FAF) | 100 | 138.2 | +38.2% |
| Cboe Global Markets… (CBOE) | 100 | 318.1 | +218.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FNF vs ICE vs CME vs FAF vs CBOE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FNF has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.
- Dividend streak 10 yrs, beta 0.58, yield 4.0%
- Lower volatility, beta 0.58, Low D/E 53.1%, current ratio 2.44x
- Beta 0.58, yield 4.0%, current ratio 2.44x
- Lower P/E (8.7x vs 23.5x)
ICE ranks third and is worth considering specifically for stability.
- Beta 0.33 vs FAF's 0.59
CME is the clearest fit if your priority is quality.
- 62.0% margin vs FNF's 4.2%
FAF is the clearest fit if your priority is growth exposure.
- Rev growth 21.6%, EPS growth 376.2%, 3Y rev CAGR -0.7%
- 21.6% revenue growth vs CME's 6.4%
CBOE is the #2 pick in this set and the best alternative if long-term compounding and valuation efficiency is your priority.
- 463.6% 10Y total return vs CME's 284.9%
- PEG 1.38 vs ICE's 2.19
- +45.8% vs FNF's -18.7%
- 12.2% ROA vs FNF's 0.6%, ROIC 17.9% vs 10.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.6% revenue growth vs CME's 6.4% | |
| Value | Lower P/E (8.7x vs 23.5x) | |
| Quality / Margins | 62.0% margin vs FNF's 4.2% | |
| Stability / Safety | Beta 0.33 vs FAF's 0.59 | |
| Dividends | 4.0% yield, 10-year raise streak, vs FAF's 3.1% | |
| Momentum (1Y) | +45.8% vs FNF's -18.7% | |
| Efficiency (ROA) | 12.2% ROA vs FNF's 0.6%, ROIC 17.9% vs 10.1% |
FNF vs ICE vs CME vs FAF vs CBOE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FNF vs ICE vs CME vs FAF vs CBOE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CBOE leads in 2 of 6 categories
CME leads 1 • FNF leads 1 • ICE leads 0 • FAF leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FNF is the larger business by revenue, generating $14.3B annually — 3.0x CBOE's $4.7B. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to FNF's 4.2%. On growth, FNF holds the edge at +15.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $14.3B | $12.6B | $6.5B | $6.0B | $4.7B |
| EBITDAEarnings before interest/tax | $2.2B | $6.5B | $4.7B | $1.1B | $1.6B |
| Net IncomeAfter-tax profit | $602M | $3.3B | $4.2B | $673M | $1.1B |
| Free Cash FlowCash after capex | $6.0B | $4.3B | $4.4B | $824M | $1.2B |
| Gross MarginGross profit ÷ Revenue | +65.1% | +61.9% | +86.1% | +74.3% | +48.9% |
| Operating MarginEBIT ÷ Revenue | +9.8% | +38.7% | +64.9% | +14.8% | +32.1% |
| Net MarginNet income ÷ Revenue | +4.2% | +26.1% | +62.0% | +11.2% | +23.3% |
| FCF MarginFCF ÷ Revenue | +42.4% | +33.9% | +64.3% | +13.7% | +24.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.2% | — | — | -90.9% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -126.1% | +23.1% | +21.4% | +70.4% | +59.7% |
Valuation Metrics
FNF leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.6x trailing earnings, FAF trades at a 64% valuation discount to CBOE's 32.5x P/E. Adjusting for growth (PEG ratio), CBOE offers better value at 1.66x vs ICE's 3.05x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $13.5B | $88.4B | $104.1B | $7.1B | $35.5B |
| Enterprise ValueMkt cap + debt − cash | $15.9B | $107.9B | $103.4B | $7.7B | $34.9B |
| Trailing P/EPrice ÷ TTM EPS | 22.75x | 27.06x | 25.70x | 11.63x | 32.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.69x | 19.48x | 23.49x | 10.87x | 27.00x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.05x | 1.87x | — | 1.66x |
| EV / EBITDAEnterprise value multiple | 7.00x | 16.71x | 22.96x | 7.34x | 21.35x |
| Price / SalesMarket cap ÷ Revenue | 0.93x | 7.00x | 15.96x | 0.96x | 7.52x |
| Price / BookPrice ÷ Book value/share | 1.52x | 3.08x | 3.60x | 1.32x | 6.93x |
| Price / FCFMarket cap ÷ FCF | 2.12x | 20.62x | 24.82x | 9.36x | 30.76x |
Profitability & Efficiency
CBOE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CBOE delivers a 23.0% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $7 for FNF. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ICE's 0.70x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs CME's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.7% | +11.6% | +15.3% | +12.5% | +23.0% |
| ROA (TTM)Return on assets | +0.6% | +2.3% | +2.2% | +4.0% | +12.2% |
| ROICReturn on invested capital | +10.1% | +7.5% | +10.2% | +10.7% | +17.9% |
| ROCEReturn on capital employed | +1.8% | +9.5% | +3.6% | +5.3% | +22.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 9 | 5 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.53x | 0.70x | 0.13x | 0.35x | 0.33x |
| Net DebtTotal debt minus cash | $2.4B | $19.4B | -$666M | $519M | -$532M |
| Cash & Equiv.Liquid assets | $2.4B | $837M | $4.4B | $1.4B | $2.2B |
| Total DebtShort + long-term debt | $4.8B | $20.3B | $3.8B | $1.9B | $1.7B |
| Interest CoverageEBIT ÷ Interest expense | 6.77x | 6.53x | 41.55x | 6.45x | 40.58x |
Total Returns (Dividends Reinvested)
CBOE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CBOE five years ago would be worth $32,366 today (with dividends reinvested), compared to $12,070 for FAF. Over the past 12 months, CBOE leads with a +45.8% total return vs FNF's -18.7%. The 3-year compound annual growth rate (CAGR) favors CBOE at 36.4% vs FAF's 9.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.4% | -2.1% | +9.1% | +15.1% | +36.8% |
| 1-Year ReturnPast 12 months | -18.7% | -10.4% | +4.6% | +17.8% | +45.8% |
| 3-Year ReturnCumulative with dividends | +63.6% | +50.8% | +71.4% | +30.7% | +153.6% |
| 5-Year ReturnCumulative with dividends | +33.8% | +43.4% | +64.5% | +20.7% | +223.7% |
| 10-Year ReturnCumulative with dividends | +170.1% | +225.3% | +284.9% | +138.4% | +463.6% |
| CAGR (3Y)Annualised 3-year return | +17.8% | +14.7% | +19.7% | +9.3% | +36.4% |
Risk & Volatility
Evenly matched — CME and CBOE each lead in 1 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than FAF's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBOE currently trades 97.7% from its 52-week high vs FNF's 77.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.58x | 0.33x | -0.30x | 0.59x | -0.27x |
| 52-Week HighHighest price in past year | $64.98 | $189.35 | $329.16 | $71.47 | $346.48 |
| 52-Week LowLowest price in past year | $42.78 | $143.17 | $257.17 | $53.09 | $212.75 |
| % of 52W HighCurrent price vs 52-week peak | +77.4% | +82.5% | +87.1% | +97.6% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 38.8 | 44.1 | 62.4 | 75.2 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 3.0M | 2.2M | 945K | 878K |
Analyst Outlook
Evenly matched — FNF and FAF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FNF as "Buy", ICE as "Buy", CME as "Hold", FAF as "Buy", CBOE as "Hold". Consensus price targets imply 33.3% upside for FNF (target: $67) vs -12.6% for CBOE (target: $296). For income investors, FNF offers the higher dividend yield at 3.99% vs CBOE's 0.80%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $67.00 | $195.71 | $320.25 | $83.00 | $296.00 |
| # AnalystsCovering analysts | 17 | 36 | 35 | 15 | 31 |
| Dividend YieldAnnual dividend ÷ price | +4.0% | +1.2% | +3.8% | +3.1% | +0.8% |
| Dividend StreakConsecutive years of raises | 10 | 14 | 6 | 15 | 10 |
| Dividend / ShareAnnual DPS | $2.01 | $1.93 | $10.92 | $2.15 | $2.71 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +1.6% | +0.3% | +1.7% | +0.3% |
CBOE leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). CME leads in 1 (Income & Cash Flow). 2 tied.
FNF vs ICE vs CME vs FAF vs CBOE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FNF or ICE or CME or FAF or CBOE a better buy right now?
For growth investors, First American Financial Corporation (FAF) is the stronger pick with 21.
6% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). First American Financial Corporation (FAF) offers the better valuation at 11. 6x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate Fidelity National Financial, Inc. (FNF) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FNF or ICE or CME or FAF or CBOE?
On trailing P/E, First American Financial Corporation (FAF) is the cheapest at 11.
6x versus Cboe Global Markets, Inc. at 32. 5x. On forward P/E, Fidelity National Financial, Inc. is actually cheaper at 8. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cboe Global Markets, Inc. wins at 1. 38x versus Intercontinental Exchange, Inc. 's 2. 19x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — FNF or ICE or CME or FAF or CBOE?
Over the past 5 years, Cboe Global Markets, Inc.
(CBOE) delivered a total return of +223. 7%, compared to +20. 7% for First American Financial Corporation (FAF). Over 10 years, the gap is even starker: CBOE returned +463. 6% versus FAF's +138. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FNF or ICE or CME or FAF or CBOE?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 30β versus First American Financial Corporation's 0. 59β — meaning FAF is approximately -295% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 70% for Intercontinental Exchange, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FNF or ICE or CME or FAF or CBOE?
By revenue growth (latest reported year), First American Financial Corporation (FAF) is pulling ahead at 21.
6% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: First American Financial Corporation grew EPS 376. 2% year-over-year, compared to -52. 5% for Fidelity National Financial, Inc.. Over a 3-year CAGR, FNF leads at 8. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FNF or ICE or CME or FAF or CBOE?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus 4. 2% for Fidelity National Financial, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 9. 9% for FNF. At the gross margin level — before operating expenses — FNF leads at 98. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FNF or ICE or CME or FAF or CBOE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Cboe Global Markets, Inc. (CBOE) is the more undervalued stock at a PEG of 1. 38x versus Intercontinental Exchange, Inc. 's 2. 19x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Fidelity National Financial, Inc. (FNF) trades at 8. 7x forward P/E versus 27. 0x for Cboe Global Markets, Inc. — 18. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FNF: 33. 3% to $67. 00.
08Which pays a better dividend — FNF or ICE or CME or FAF or CBOE?
All stocks in this comparison pay dividends.
Fidelity National Financial, Inc. (FNF) offers the highest yield at 4. 0%, versus 0. 8% for Cboe Global Markets, Inc. (CBOE).
09Is FNF or ICE or CME or FAF or CBOE better for a retirement portfolio?
For long-horizon retirement investors, Cboe Global Markets, Inc.
(CBOE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 27), 0. 8% yield, +463. 6% 10Y return). Both have compounded well over 10 years (CBOE: +463. 6%, FAF: +138. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FNF and ICE and CME and FAF and CBOE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FNF is a mid-cap income-oriented stock; ICE is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock; FAF is a small-cap high-growth stock; CBOE is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.